The Risk Adjustment Vendor Shakeout: Who Survives the Compliance Era and Who Doesn’t
The Market Is Splitting
The risk adjustment vendor market is undergoing a shakeout driven by regulatory pressure, not competitive dynamics. For 15 years, vendors competed primarily on volume, speed, and price. Who could process the most charts? Who delivered the fastest turnaround? Who offered the lowest per-chart rate? These criteria worked when the market rewarded code capture above all else.
The enforcement environment changed the selection criteria. DOJ settlements exceeding $670 million established that program design choices create federal liability for the plan, not the vendor. OIG’s February 2026 compliance guidance identified add-only methodology as a high-risk practice. CMS scaled its audit workforce to approximately 2,000 coders with AI-assisted targeting. Plans are now selecting vendors on defensibility, methodology, and compliance architecture rather than throughput and cost.
This shift is splitting the market into two categories: vendors that restructured for the compliance era and vendors still operating programs designed for the capture era. The split is accelerating because plans are consolidating their vendor relationships, and the vendors that don’t meet the new criteria are losing contracts they’ve held for years.
What Compliance-Era Vendors Look Like
Vendors surviving the shakeout share four characteristics. First, they operate two-way chart review as standard methodology, not as an optional add-on. Every engagement includes systematic identification of codes to add and codes to remove. Deletion metrics are tracked, reported, and used as quality indicators.
Second, their AI is explainable. Every coding recommendation comes with documented reasoning: which clinical text was evaluated, which MEAT elements were identified, and why the system concluded the documentation does or doesn’t support the diagnosis. The plan’s compliance team can audit the vendor’s AI logic independently.
Third, they produce audit-ready output by default. Every delivered code includes a pre-built evidence package (clinical note reference, MEAT mapping, defensibility score) formatted for RADV response. The plan doesn’t need to reconstruct evidence trails from vendor deliverables during audit response.
Fourth, they accept contractual accountability for quality. They agree to defensibility guarantees, independent quality audits by the plan, and SLAs tied to evidence quality rather than just volume. Vendors confident in their methodology accept this accountability. Vendors whose methodology wouldn’t survive scrutiny resist it.
What Capture-Era Vendors Look Like
Vendors losing ground share opposite characteristics. They lead with RAF uplift projections and volume metrics in sales conversations. They resist or can’t provide deletion rates across their client base. Their AI produces recommendations without transparent reasoning, making compliance audits of their decision logic difficult or impossible. Their deliverables consist of code lists that require significant rework before they’re audit-ready.
Some capture-era vendors have attempted to retrofit compliance features onto revenue-optimized platforms. They add a MEAT validation checkbox. They include an optional deletion workflow. They generate an evidence report as a secondary output. These retrofits address the symptoms without changing the architecture. The system still optimizes for finding codes. The compliance features compete with that optimization rather than reinforcing it.
Plans can identify capture-era vendors through a simple test: ask for their average deletion rate across all clients for the past four quarters. Vendors that can produce this number and it’s meaningful (5%+ of total coding activity) have built deletion into their process. Vendors that can’t produce it, or produce a number near zero, are operating the methodology OIG flagged as high-risk.
Choosing for the Next Five Years
The shakeout will produce a smaller, more specialized vendor market where the survivors compete on defensibility rather than volume. Plans selecting risk adjustment vendors today are choosing partners for a regulatory environment that will only intensify. The right selection criterion isn’t who processes the most charts at the lowest cost. It’s whose methodology produces output that holds up when CMS’s 2,000 auditors, supplemented by AI pattern detection, examine it. That criterion eliminates capture-era vendors and concentrates contracts with the compliance-era vendors who rebuilt for exactly this moment.
